Breaking

Treasury targets oil traders, tankers accused of helping Maduro evade U.S. sanctions
DOJ outlines 10 ‘wins’ under Trump, says agency restored after Biden era
Black Republican calls for total, permanent abolition of DEI: ‘I want to earn every opportunity on merit’
Zinc Stocks: 5 Biggest Canadian Companies in 2025
Rio Silver Inc. Completes Securities for Debt Transaction
Goldgroup Enters Into Agreement To Sell Subsidiary Minera Apolo, S.A. de C.V., Disposing of Pinos Project
Ukraine–Russia at a crossroads: How the war evolved in 2025 and what comes next
Congress blocks Obamacare subsidies after shutdown fight, premiums set to surge

Business
Politics
Investing
World
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Zinc Stocks: 5 Biggest Canadian Companies in 2025

January 1, 2026

Rio Silver Inc. Completes Securities for Debt Transaction

January 1, 2026

Goldgroup Enters Into Agreement To Sell Subsidiary Minera Apolo, S.A. de C.V., Disposing of Pinos Project

January 1, 2026

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,184)
- Investing (4,475)
- Politics (5,961)
- World (4,286)

Disclaimer: MicroStocksSecrets.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 microstockssecrets.com | All Rights Reserved

Top

Business
Politics
Investing
World

Type above and press Enter to search. Press Esc to cancel.